Citation Impact

Citing Papers

Hypoxia-Inducible Factors and the Response to Hypoxic Stress
2010 Standout
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice
2005
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
2006 Standout
Non Alcoholic Fatty Liver: Epidemiology and Natural History
2015
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: Cosponsored by american association of clinical endocrinologists, The obesity society, and american society for metabolic & bariatric surgery*
2013 Standout
Epidemiology of Non-Alcoholic Fatty Liver Disease
2010
Preliminary Study of Ciprofloxacin in Active Crohn's Disease
2002
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Lack of Exercise Is a Major Cause of Chronic Diseases
2012 Standout
Pattern of liver function tests in morbidly obese Saudi patients undergoing bariatric surgery
2011
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
2011 Standout
Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet
2008
Histological Behavior of Hepatic Steatosis in Morbidly Obese Patients after Weight Loss Induced by Bariatric Surgery
2005
Insulin and insulin resistance:
2004 Standout
The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population
2006 Standout
Nonalcoholic fatty liver disease
2005 Standout
The Role of Ultrasound in the Diagnosis of Hepatic Steatosis in Morbidly Obese Patients
2004
Prevalence of Non-alcoholic Steatohepatitis in Morbidly Obese Subjects Undergoing Gastric Bypass
2003
European Guidelines for Obesity Management in Adults
2015 Standout
Management of Crohn's Disease in Adults
2009 Standout
Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question
2007
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Molecular Mechanisms of the Anti-Obesity and Anti-Diabetic Properties of Flavonoids
2016 Standout
Assessing Adiposity
2011
Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor-1α
2006 StandoutNobel
The clinical biochemistry of obesity.
2004
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
2011 StandoutNobel
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
2017 Standout
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
2017 Standout

Works of Luca Boschi being referenced

Liver Damage in Obese Patients
2002
Surgery in Crohn's disease: when, where and why the recurrences?
1998
Rankless by CCL
2026